Silence Therapeutics plc Adjustments For Finance Income
Silence Therapeutics plc (SLN) reported Adjustments For Finance Income of GBP 1.45 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-13.
Discontinued › Income Statement › Other Income
ifrs-full:AdjustmentsForFinanceIncome · last filed 2024-03-13
| Period end | Adjustments For Finance Income 12 month | Adjustments For Finance Income 12 month as first filed |
|---|---|---|
| 2023-12-31 | 1.45M GBP 20-F · filed 2024-03-13 | |
| 2022-12-31 | 1.27M GBP 20-F · filed 2024-03-13 | |
| 2021-12-31 | 10.00K GBP 20-F · filed 2024-03-13 | |
| 2020-12-31 | 128.00K GBP 20-F · filed 2023-03-15 | 129.00K GBP 20-F/A · filed 2021-04-29 |
| 2019-12-31 | 27.00K GBP 20-F · filed 2022-03-17 | |
| 2018-12-31 | 39.00K GBP 20-F/A · filed 2021-04-29 |